Treatment of conjunctival epithelial tumors: Brachytherapy with ruthenium-106;Traitement des tumeurs épithéliales de la conjonctive: Intérêt de la curiethérapie au Ruthénium-106

Journal Francais d'Ophtalmologie

Volumn 26, Issue 9, 2003, Pages 929-939

  Buc, D ^a,c   Pilon, F ^a   Donnarieix, D ^b   Kemeny, J L ^a   Bacin, F ^a   Rigal, D ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c Hôpital Porte Madeleine   (France)

Author keywords

Brachytherapy; Conjunctival epithelial tumors; Ruthenium 106

Indexed keywords

RUTHENIUM 106;

ADULT; ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; CONJUNCTIVA EPITHELIUM; CONJUNCTIVA EPITHELIUM TUMOR; CONJUNCTIVA TUMOR; CONTROLLED STUDY; EPITHELIUM TUMOR; EVALUATION; FEMALE; FOLLOW UP; HUMAN; MALE; RADIATION DOSE; RADIOISOTOPE THERAPY; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY; BRACHYTHERAPY; CONJUNCTIVAL NEOPLASMS; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; POSTOPERATIVE CARE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RUTHENIUM RADIOISOTOPES; SEX DISTRIBUTION; STRONTIUM RADIOISOTOPES; TREATMENT OUTCOME;

EID: 0344845336     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Zimmerman LE, Sobin LH. Histological typing of tumors of the Eye and its Adnexa. Geneva: World Health Organisation, 1980;24:29-31.
2. Tabin G, Levin S, Snibson G, Loughnan M, Taylor H. Late recurrences and the necessitty for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology, 1997;104:492-5.
3. Lee GA, Hirst W. Incidence of ocular surface epithelial dysplasia in metropolitan Brisbane. A 10-year survey. Arch Ophthalmol, 1992;110:525-7.
4. Lederman M. The foundation of ophthalmology. Radiotherapy; In: Duke-Elder S (ed.): System of ophthalmology, vol. 8, London, Henry Kimpton, 1962.
5. Fayos JV, Wild dermuth O. Carcinoma of the ocular conjunctiva: its treament with roentgen irradiation. Radiology, 1962;79:582-7.
6. Hughes WF, Iliff CE. Beta-irradiation of the eye. Am J Ophthalmol, 1949;32:351-60.
7. Rozan R, Bacin F, Albuisson E, Dalens H, Donnarieix D, Verrelle P. Plaque therapy for uveal malignant melanoma. Brachytherapy Journal, 1992;supp.3:51-8.
8. Zehetmayer M, Menepace R, Kulnig W. Combined local excision and brachytherapy with ruthenium-106 in the treament of epibulbar malignancies. Ophthalmologica, 1993;207:133-9.
9. Hertle RW, Durso F, Mtzler JP, Varsa EW. Epibulbar squamous cell carcinomas in brothers with xeroderma pigmentosum. J Pediatr Ophthalmol Strabismus, 1991;28:350-3.
10. Erie JC, Campbell JR, Liesegang J. Cunjunctival and corneal intaepithelial and invasive neoplasia. Ophthalmology, 1986;93:176-83.
11. Ash JE. Epibulbar tumor. Am J Ophthalmol, 1950;33:1203-19.
12. Ni C, Searl SS, Kriegstein HJ, Wu BF. Epibulbar carcinoma. Int Ophthalmol Clin, 1982;22:1-33.
13. Tseng SCG. Concept and application of limbal stem cells. Eye, 1989;3:141-57.
14. Trosko JE, Krause D, Isoun M. Sunlight-induced pyrimidine dimmers in human cells in vitro. Nature, 1970;228:358-9.
15. Brash DE, Rudolph JA, Simon JA, et al. A role of sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA, 1991;88:10124-8.
16. Mc Donnell JM, Mc Donnell PJ, Sun YY. Human papilloma-virus DNA in tissues and ocular surface swabs of patients with conjunctival intraepithelial neoplasia Invest Ophthalmol Vis Sci, 1992;33:184-9.
17. Sevel D, Rossall S. Pterygia and carcinoma of the conjunctiva. Trans Ophthalmol Soc UK, 1968;88:567-78.
18. Gaasterland E, Rodrigues MM, Moshell AN. Ocular involvement in Xeroderma Pigmentosum. Ophthalmology, 1982;89:980-6.
19. Margo CE, Mack W, Guffey JM. Squamous cell carcinoma of the conjunctiva and human immunodeficiency virus infection. Arch Ophthalmol, 1996;114:349.
20. Kushner FH, Mushen RL. Conjunctival squamous cell carcinoma combined with malignant lymphoma. Am J Ophthalmol, 1975;80:503-6.
21. Char DH. Management of lid and conjunctival malignancies. Surv Ophthalmol, 1980;104;679-89.
22. Miller GR. Circum-limbal carcinoma in situ. Arch Ophthalmol, 1965;74:68-78.
23. Cha SB, Shields CL, Shields JA, Eagle RC, De Potter P, Talansky M. Massive precorneal extension of squamous cell carcinoma of the conjunctiva. Cornea, 1993;12:537-40.
24. Reese A. Tumors of the eye. New York, Harper and Roow, third edition, 1976.
25. Cameron JA, Hidayat AA. Squamous cell carcinoma of the cornea. Am J Ophthalmol, 1991;11:574-4.
26. Irvine AR Jr. Epibulbar squamous cell carcinoma and related lesions. Int Ophthalmol Clin, 1972;12:71-83
27. Tunc M, Char DH, Crawford B, Miller T. Intraepithelial and invasif squamous cell carcinoma of the conjunctiva. Br J Ophthalmol, 1999;83:98-103.
28. Irvine AR JR. Diffuse epibulbar squamous cell epithelioma. Am J Ophthalmol, 1967;64:550-4.
29. Cerezo L, Otero J, Aragon G, Polo H, De la Torre A, Valcarcel F, Magallon R. Conjunctival intraepithelial and invasive squamous cell carcinomas treated with strontium-90. Radiother Oncol, 1989;17:191-7.
30. Fraunfelder FT, Wingfield D. Management of intraepithelial conjunctival tumors and squamous cell carcinomas. Am J Ophthalmol, 1983;95:359-63.
31. Sudesh S, Rapuano CJ, Cohen EJ, Eagle RC, Laibson PR. Surgical management of ocular surface squamous neoplasms. Cornea, 2000;19:278-83.
32. Peksayar G, Soyturk MK, Demiryont M. Long-term results of cryotherapy on malignant epithelial tumors of the conjunctiva. Am J Ophthalmol, 1989;107:337-49.
33. Wilson MW, Hungerford JL, George SM, Madreperla SA. Topical mitomycine C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol, 1997;124:303-11.
34. Midena E, Degli-Angeli C, Valenti M, De Belvis V, Boccato P. Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil. Br J Ophtalmol, 2000;84:268-72.
35. Vann RR, Karp CL. Perilesional and topical interferon Alfa-2b for conjunctival and corneal neoplasia. Ophthalmology, 1999;106:91-7.
36. Irvine AR Jr. Dyskeratotic epibulbar tumors. Tran Am Ophthalmol Soc, 1963;61:243-73.
37. Lommatzsch P, Vollmar R. Results of beta-therapy in epibulbar tumors. Klin Monatsbl Augenh, 1964;144:856-71.
38. Kaae S. Carcinoma at the corneal limbus treated with strontium 90 applicator. Act Ophthalmol, 1954;32:69-75.
39. Mc Donald JE, Wilson FM. Ocular therapy with beta partides. Trans Am Acad Ohthal Otolaryng, 1959;63:468-85.
40. Lommatzsch P. Beta-ray treatment of malignant epithelial tumors of the conjunctiva. Am J Ophthalmol, 1976;81:200-6.
41. Elkon D, Constable WC. The use of strontium-90 in the treament of carcinoma in situ of the conjuctiva. Am J Ophthalmol, 1979;87:84-6.
42. Kearsley JH, Fitchew RS, Taylor RGS. Adjunctive radiotherapy with strontium-90 in the treatment of conjunctival squamous cell carcinoma. Int J Radiat Oncol Biol Phys, 1988;14:435-43.
43. Jones DB, Wilhelmus KR, Font RL. Beta radiation of recurrent corneal intra epithelial neoplasia. Trans Am J Ophthalmol, 1991;89;285-301.
44. Sanders N, Bedotto C. Recurrent carcinoma in situ of the conjunctiva and cornea (Bowen's disease). Am J Ophthalmol, 1972;74:688-93.
45. Barron A, McDonald JE, Hughes WF. Long-term complications of beta radiation therapy in ophthalmology. Trans Am Ophthal Soc, 1978;68:113-28.